5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II trial of the prostate-specific membrane antigen (PSMA)-targeted immunoconjugate MLN2704 in patients (pts) with progressive metastatic castration resistant prostate cancer (CRPC)
    Meeting Abstract

    Milowsky, M. I.; Galsky, M.; George, D. J.; Lewin, J. M.; Rozario, C. P.; Marshall, T.; Chang, M.; Nanus, D. M.; Webb, I. J.; Scher, H. I.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Correlative results of in-vivo monitoring of platelet-derived growth factor receptor (PDGFR) activation status in a randomized placebo-controlled trial of docetaxel +/- imatinib in castration-resistant prostate cancer (CRPC) and bone metastases (BM)
    Meeting Abstract

    Mathew, P.; Thall, P. F.; Wen, S.; Horne, E.; Johnson, M.; Oh, W. K.; Morris, M. J.; Logothetis, C. J.; Fidler, I. J.; Bucana, C.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • Preliminary results of a randomized placebo-controlled,double-blind trial of weekly docetaxel combined with imatinib in men with metastatic androgen-independent prostate cancer (AIPC) and bone metastases (BM)
    Meeting Abstract

    Mathew, P.; Thall, P. F.; Johnson, M. M.; Oh, W. K.; Meluch, A. A.; Morris, M. J.; Troncoso, P.; Bucana, C. D.; Fidler, I. J.; Logothetis, C. J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Pegylated interferon alpha-2B (PEG-Intron) for metastatic renal cell cancer (mRCC): Results of a phase II clinical trial and biologic correlates of response
    Meeting Abstract

    Kondagunta, G. V.; Bacik, J.; Ishill, N.; Reuter, V.; Schwartz, L. H.; Korkola, J.; Deluca, J.; Sweeney, S.; Chaganti, R. S. K.; Motzer, R. J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Pharmacokinetics (PK) and efficacy of sunitinib in patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Houk, B. E.; Amantea, M.; Motzer, R. J.; Michaelson, M. D.; Rini, B. I.; George, D. J.; Redman, B. G.; Hudes, G. R.; Poland, B.; Bello, C. L.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Prospective trial of ifosfamide, paclitaxel, and cisplatin (ITP) in patients with advanced non-transitional cell (non-TCC) carcinomas of the urothelial tract
    Meeting Abstract

    Galsky, M. D.; Iasonos, A.; Mironov, S.; Scattergood, J.; Donat, S. M.; Bochner, B. H.; Herr, H. W.; Russo, P.; Boyle, M. G.; Bajorin, D. F.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Phase II study of volociximab (M200), an alpha 5 beta 1 anti-integrin antibody in refractory metastatic clear cell renal cell cancer (RCC)
    Meeting Abstract

    Figlin, R. A.; Kondagunta, G. V.; Yazji, S.; Motzer, R. J.; Bukowski, R. M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A brief symptom index for renal cell carcinoma
    Meeting Abstract

    Eton, D. T.; Cello, D.; Bacik, J.; Motzer, R. J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • The probability of a positive bone scan in patients who were treated with adrogen ablasio therapy for rising PSA after radical prostatectomy
    Meeting Abstract

    Dotan, Z. A.; Sathyamoorthy, K.; Bianco, F. J.; Stephenson, A. J.; Eastham, J. A.; Fearn, P.; Schoder, H.; Scher, H. I.; Scardino, P. T.; Kattan, M. W.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Systems pathology for building predictive models: The androgen receptor as a prototype biomarker in prostate cancer progression and targeted therapeutic response assessment
    Meeting Abstract

    Donovan, M. J.; Scher, H.; Scardino, P.; Kotsianti, A.; Cordon-Cardo, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save